Source: UNIV OF IDAHO submitted to NRP
NANOPARTICLE-BASED SEPARATION OF PLANT EXTRACELLULAR VESICLES FOR SILENCING VIRULENCE GENES
Sponsoring Institution
National Institute of Food and Agriculture
Project Status
COMPLETE
Funding Source
Reporting Frequency
Annual
Accession No.
1028230
Grant No.
2022-67022-36600
Cumulative Award Amt.
$200,000.00
Proposal No.
2021-08554
Multistate No.
(N/A)
Project Start Date
Mar 1, 2022
Project End Date
Feb 28, 2025
Grant Year
2022
Program Code
[A1511]- Agriculture Systems and Technology: Nanotechnology for Agricultural and Food Systems
Recipient Organization
UNIV OF IDAHO
875 PERIMETER DRIVE
MOSCOW,ID 83844-9803
Performing Department
Chemical & Biological Engr.
Non Technical Summary
Crop pathogens and pests reduce approximately 20-30% annual yield of agricultural production. This has led to substantial economic losses and reduction in food security at national and global levels. Plant-derived extracellular vesicles (EVs) secreted during plant-pathogen interactions gain more and more attention to suppress the expression of pathogen's virulence-related genes. The overarching goal of this seed grant proposal is to provide agriculture sectors in the USA with environmentally friendly approaches for better pest and disease control, crop protection, and agricultural production, using a sustainable eco-friendly gene-silencing approach. As the first step, we will conduct a proof-of-concept study using biodegradable chitosan nanoparticles to incorporate the C1C2 domain of lactadherin (lactC1C2) via biotin-streptavidin binding to replace labor- and time-intensive differential ultracentrifugation for the isolation of phosphatidylserine-exposing plant EVs. To do so, we will first design, synthesize, and characterize nanoparticles incorporating chitosan, biotin-streptavidin complex, and lactC1C2 for the purification of plant EVs. Then, the efficacy of preventing pathogen infection using purified plant EVs tethered with nanoparticles will be investigated. The specific aims of this seed grant project are to 1) construct expression vectors containing lactC1C2-streptavidin fusion gene for bacterial transformation, protein expression and purification, 2) fabricate lactC1C2-streptavidin-bound chitosan nanoparticles associated with EVs secreted from Arabidopsis thaliana leaves infected with necrotrophic fungus Botrytis cinerea, and 3) examine the efficacy of EV-nanoparticle hybrids on silencing virulence genes of B. cinerea. The successful outcome of this project will lay the framework for PD to become competitive for future grants from AFRI. ?
Animal Health Component
100%
Research Effort Categories
Basic
(N/A)
Applied
100%
Developmental
(N/A)
Classification

Knowledge Area (KA)Subject of Investigation (SOI)Field of Science (FOS)Percent
40224992020100%
Knowledge Area
402 - Engineering Systems and Equipment;

Subject Of Investigation
2499 - Plant research, general;

Field Of Science
2020 - Engineering;
Goals / Objectives
The long-term goal of this proposed project is to provide agriculture in the USA with environmentally friendly approaches for better pest and disease control, crop protection, and agricultural production. The goal will be achieved through (1) design and synthesis of nanoparticles incorporating chitosan, biotin-streptavidin complex, and lactadherin C1C2 domain for the purification of plant extracellular vesicles (EVs) and (2) study of the efficacy of preventing pathogen infection using purified plant EVs tethered with nanoparticles. Accomplishment of this goal would greatly contribute to the rural economy, the welfare of farmers, and our society in general.Objectives: Control of pests and pathogenic diseases has traditionally relied on pesticide/fungicide sprays. These tools not only threaten the human health and ecosystem but also generate uncontrollable multidrug-resistant pathogenic strains. Thus, alternative approaches to manage pests and pathogenic bacteria in a sustainable and eco-friendly manner are needed to maintain high crop production. Using natural compounds instead of synthetic compounds for pest and disease control is much more desirable because they are environmentally friendly. Silencing virulence genes of pests and pathogens is an approach which utilizes naturally occurring small RNAs carried by plant secreted EVs. It has been demonstrated that plant-originated EVs during plant-microbe interaction play prominent roles in plant immune responses. Multiple methods have been developed for isolating EVs from fluids. However, up-to-date, the more widely accepted method for isolating plant EVs is differential ultracentrifugation because the immune-affinity capture approach, depending on suitable EV biomarkers, has not been commercially available for the isolation of EVs from plants. Although time-consuming and labor-intensive, differential ultracentrifugation has remained as the most widely used method for EV purification. To meet the increasing use of EVs, there is an urgent need of more efficient and reliable methods for isolating large amounts of highly pure EVs.For this seed grant proposal, PD will initiate a proof-of-concept investigation using biodegradable chitosan nanoparticles to incorporate the C1C2 domain of lactadherin (lactC1C2) via biotin-streptavidin binding to replace the time-consuming differential ultracentrifugation for the isolation of phosphatidylserine-exposing plant EVs. The successful outcome of this proposed study will lay the framework for PD to pursue future AFRI grants. To accomplish the goals set by this seed grant project, specific studies will be conducted with the following objectives.Objective 1: To construct expression vectors containing lactC1C2-streptavidin fusion gene for bacterial transformation, protein expression and purificationObjective 2: To incorporate lactC1C2-streptavidin-bound chitosan nanoparticles with EVs secreted from Arabidopsis thaliana leaves infected with fungal pathogen Botrytis cinereaObjective 3: To examine the efficacy of EV-nanoparticle hybrids on silencing virulence genes of B. cinerea
Project Methods
Task 1: Expression and purification of lactC1C2-coreSA fusion proteinConstruction of lactadherin C1C2-coreSA encoding plasmid The lactC1C2-coreSA encoding recombinant plasmid (pMA002) will be constructed by inserting the gene sequences of lactadherin C1C2 domain into the multiple cloning sites from EcoRV and EcoRI in the established plasmid pMA001 (i.e., pET-30a(+)-coreSA). The lactC1C2 domain gene will be cloned from the plasmid encoding C1C2 domain, acquired from Addgene (plasmid Cat # 52987), by polymerase chain reaction (PCR) with forward primer 5'- ATTAAGATATCTGTTCTACACAGCTGGGC-3' and reverse primer 5'- ATTAAGAATTCACAGCCCAGCAGCTCCAG-3'. LactC1C2 PCR reactions will be performed with previously reported DNA polymerase, times, temperatures, and cycles. The PCR products of lactC1C2 will be purified through the PCR purification kit (NEB) and analyzed by 1% agarose gel electrophoresis. The pMA001 plasmid and lactC1C2 cDNA (insert) will be cut with restriction enzymes EcoRV and EcoRI. The digested pMA001 and lactC1C2 products will be ligased to get the pMA002 plasmid. The pMA002 ligation product will be amplified by transformation with subcloning efficiency DH5α competent cells and purified by QIAGEN Plasmid Maxi Kit. The concentration and purity of pMA002 plasmid will be determined by a microplate reader (SpectraMax M2e, Molecular Devices). The gene sequences encoding lactC1C2 and coreSA from pMA002 cloned by PCR will be verified by DNA gel electrophoresis.Expression and purification of lactadherin C1C2-coreSA protein The constructed pMA002 plasmid will be transformed into T7 Express Lemo21(DE3) competent E. coli cells and have lactC1C2-coreSA fusion protein expressed using the protocols described previously by the PD. Expressed lactC1C2-coreSA fusion protein with 6×His tag will be purified by IMAC Co-NTA affinity chromatography and characterized by SDS?PAGE and Western blotting analysis. To determine the concentration of the eluted lactC1C2-coreSA fusion protein, the bicinchoninic acid (BCA) protein assay kit (Pierce) will be used according to the manufacturer's instructions. The purified lactC1C2-coreSA fusion protein can be easily bound onto biotinylatednanoparticles.Task 2: Incorporation of lactC1C2-coreSA-bound chitosan nanoparticles with EVs secreted from Arabidopsis thaliana leavesFabrication of chitosan (CS) nanoparticles (NPs) bound with lactC1C2-coreSA Since size, shape, stability, and yield of chitosan nanoparticles highly relies on degree of deacetylation, molecular weight and concentration of chitosan used in synthesis process, three different molecular weight chitosan, derived from crab shell, in the form of fibrils flakes will be obtained from Sigma-Aldrich (Cat #: LMW 448869, MMW 448877, HMW 419419) for this proposed study. The chitosan flakes treated with 1M NaOH will be dissolved in 0.1M acetic acid solution which is filtered using a filter paper to remove residues of insoluble particles.Chitosan solutions of different concentration and molecular weight will be prepared by dissolving purified chitosan with sonication in 1% (w/v) acetic acid solution until the solution is transparent.Once dissolved, the chitosan solution is diluted with deionized water to produce chitosan solutions of different concentrations. Chitosan will be flush mixed with tripolyphosphate (TPP) to form CS NPs. Different concentrations of CS and TPP will be used to determine the CS/TPP ratios providing nanoparticles with optimal size properties. The fabricated chitosan NPs will be characterized by analytic tools (i.e., TEM, dynamic light scattering, zeta potentiometer). Then, they will be further conjugated with EZ-Link Sulfo-NHS-biotin (Pierce) via the interaction with chitosan to obtain biotinylated CS NPs. Various concentrations of lactC1C2-coreSA fusion protein will be bound with biotinylated CS NPs via biotin-streptavidin affinity. It should be noted that surface density of biotin capped on the CS NPs need to be optimized to make lactC1C2-coreSA bind to biotinylated CS NPs in a brush-like configuration instead of a mushroom-like configuration to facilitate the binding of lactC1C2 with PS-exposing EVs. Biotinylated CS NPs without lactC1C2-coreSA conjugation performed as the control group is expected to have no capability to isolate EVs.Plant EV isolation and characterization Thenecrotrophic fungal B. cinereaspores (ATCC-46522) will be diluted in 1% sabouraud maltose broth buffer to a final concentration of 2 × 105spores/mlfor plant infection. Arabidopsis thalianaecotype Columbia (Col-0) will be obtained from theArabidopsisBiological Resource Center (ABRC) for this study. Four-week-old plant leaves treated with B. cinerea at different post-inoculation times will be harvested and vacuumed with infiltration buffer (20 mM MES hydrate, 2 mM CaCl2, 0.1 M NaCl, pH 6.0) and centrifuged for 10 min at 1,000gto collect the apoplastic fluids. Plant leaves treated with inoculation medium (i.e., no B. cinerea) will also be harvested as a mock group. It is expected that EVs will accumulate to a high level at the fungal infection sites. The cellular debris in apoplastic fluids will be removed by centrifugation at 2,000gfor 30 min, followed by filtration through a 0.45-μm filter. The apoplastic wash will be further purified by centrifugation for 30 min at 10,000g. The supernatants will then be transferred to new tubes, and mixed with LactC1C2-bound CS NPs. The mixture will be centrifuged at 10,000g for 15 min to obtain nanoparticle-EV hybrids via PS specificity and affinity to lactC1C2. The obtained NP-EV hybrids will be characterized by TEM, dynamic light scattering and zeta potentiometer. For detecting proteins, the NP-EV hybrids will be boiled with SDS-loading buffer and resolved in an SDS-PAGE gel. Western blots will be conducted using antibodies against AGO1, AGO2, AGO4, AGO5 ANN2 and TET8. Total RNA will be extracted from the NP-EV hybrids with Trizol reagent. The sRNA RT-PCR products on a 12% PAGE gel will be visualized by a real-time PCR detection system using the SYBR Green mix. The time-consuming differential ultracentrifugation protocol will be used to isolate EVs as a positive control.Task 3: Efficacy of EV-nanoparticle hybrids on silencing virulence genes of B. cinereaIt has been reported that sRNAs transferred by EVs can suppress fungal pathogenicity by targeting fungal virulence genes. Of the transferredArabidopsissRNAs, TAS1c-siR483 and TAS2-siR453 was selectively accumulated in the fungal cells. TAS1c-siR483 targets twoB. cinereagenes BC1G_10728 and BC1G_10508, and TAS2-siR453 targets BC1G_08464, all of which are involved in vesicle-trafficking pathways. The expression level of B. cinerea target genes of TAS1c-siR483 and TAS2-siR453 is expected to be silenced to some extent in B. cinerea isolated from infected Arabidopsis leaves compared to B. cinerea grown on mock-treated plant samples (only inoculation medium without fungi). Various amounts of NP-EV hybrids (either obtained from plant leaves with or without fungal infection) will be dropped onto the surface of Arabidopsis leaves. Then, theB. cinereainoculum (2 × 105spores/ml) will be applied on the same spots. Disease will be assessed by measuring lesion size using ImageJ software. Quantification of fungal biomass relative to plant biomass by quantitative PCR with B. cinerea-specific primers will be performed as well.To test whether NP-EV hybrids (containing host sRNAs) are transferred into fungal cells and silence virulence genes of B. cinerea, we will profile vesicle sRNAs isolated from the extracellular apoplastic fluids of infected/uninfected leaves purified by lactC1C2-tagged chitosan NPs.

Progress 03/01/24 to 02/28/25

Outputs
Target Audience:- Research community investigating construction of recombinant plasmids, protein expression in transformed bacteria, and purification of fusion protein - Research community in the area of preventing pathogen infection using purified plant extracellular vesicles - Undergraduates and graduates involved with this research Changes/Problems: Nothing Reported What opportunities for training and professional development has the project provided?One PhD student is now familiar with recombinant plasmid construction, protein expression in T7-based bacteria system, and protein purification using affinity chromatography. This study has also learned to grow Arabidopsis thaliana and collect apoplastic washing fluids obtained from Arabidopsis leaves infected with pathogenic bacteria. The PhD student is in the final stage of completing the remaining experimental studies for the dissertation writing. One undergraduate student has been trained to grow A. thaliana, collect AWF, and use AWF to green synthesis of silver nanoparticles revealing anti-bacterial efficacy. How have the results been disseminated to communities of interest?The techniques of constructing, expressing, purifying, and characterizing lactadherin C1C2 fused proteins have been reported. The PEG-based precipitation of plant EVs have been published. One manuscript is under preparation for publishing the research outcomes of EVs separated from A. thaliana infected with P. syringe for 3 days could prevent Arabidopsis leaves from disease symptom (i.e., no yellowing or withering caused by P. syringe infection) over a long period of time. The other manuscript is also under preparation to report the efficient particle-based separation of plant EVs comparing to standard ultracentrifugation method. What do you plan to do during the next reporting period to accomplish the goals? Nothing Reported

Impacts
What was accomplished under these goals? Construction and Expression of lactadherin C1C2-streptavidin and pTXB1-lactadherin C1C2 encoding plasmid. The lactC1C2-SA encoding recombinant plasmid (pMA002) was constructed by inserting the gene sequences of lactadherin C1C2 domain into the multiple cloning sites from EcoRV and EcoRI in the established plasmid pMA001 (i.e., pET-30a(+)-coreSA). Moreover, we worked on an additional plasmid construction of pTXB1-CBD (chitin binding domain)-intein-C1C2. the gene encoding lactadherin C1C2 cloned by PCR were verified by DNA gel electrophoresis showing the size of ~0.9 kb on an agarose gel. The cloned lactadherin C1C2 was inserted between NdeI and SapI of pTXB1 plasmid. Collection of apoplastic washing fluid from Arabidopsis thaliana. Arabidopsis thaliana seeds [wild-type Arabidopsis thaliana (L.) Hyenh. Columbia-0 (Col-0)], obtained from Arabidopsis Biological Resource Center (Columbus, OH), planted by sprinkling uniformly over moist soil in plastic pots. The pots were then placed at 4°C for 4 days to allow enough time to properly germinate. On the 5th day, the pots were shifted to the growth chamber maintained at 22°C, and exposed to light (100 µmol/m2/s) with a cycle of 16 h on and 8 h off. A total of fifty leaves (fresh weight around 2 g) of 4-week-old Arabidopsis thaliana were cut at petioles, washed thrice with water, and dried on a paper towel. Dried leaves were then placed inside a needleless syringe and infiltrated with vesicle infiltration buffer.The apoplastic washing fluid (AWF) was collected, filtered with a 0.45-µm Nylon filter, and aliquoted 500 µL into three 1.5-mL microcentrifuge tubes which were stored at 4°C for follow-up experiments and at -80°C for long-term storage. Isolation of EVs from AWF by polyethylene glycol 8000 and sodium chloride. The collected AWFs (500 µL each) were mixed with various amounts of polyethylene glycol 8000 (PEG8000) to obtain 5%, 8% and 12% w/v concentration, respectively. The mixture was further added with NaCl to get 0.5 M salinity and then incubated at 4°C for 2 h and centrifuged at 10,000× g force for 30 min at 4°C using a microcentrifuge. The PEG-EVs agglomerates were sedimented at the bottom of the 1.5-mL microcentrifuge tube. The pellet was re-suspended in 1× phosphate buffered saline for characterization. Immuno dot blot assay. To examine the efficacy of EVs separated from AWF by the PEG-precipitation method, a dot blot assay was used. Briefly, for three different concentrations of PEG8000 used, 5 µL each from the supernatant and resuspended pellets was taken and carefully spotted on the nitrocellulose membrane. After 10 min of drying, the membranes were blocked using blocking buffer. Then, the membranes were incubated with mammalian monoclonal antibodies against tetraspanin proteins (CD9, CD63, and CD81) and PEG, respectively for 1 h at 4°C. After 1 h, the membranes were washed three times with TBST and incubated with secondary antibody (mouse IgG horseradish peroxide (HRP)-conjugated antibodyin the blocking buffer at 1:1000 dilution) for 1 h at room temperature.Our results showed that there is an increase in pellet size with increasing concentration of PEG8000 from 5% to 12%. The precipitation of EVs was further verified by dot blot assay of both the pellet and supernatant. The dot blot analysis that was performed using the monoclonal antibodies against mammalian tetraspanin proteins CD9, CD63, and CD81, confirmed the presence of EVs in the pellet. Characterization of PEG-precipitated EVs. The measurements for the size distribution of EVs were performed with dynamic light scattering (DLS) instrument. EVs, resuspended in 1× PBS, were appropriately diluted with 0.2-µm membrane filtered distilled water and loaded into a 750-µL cuvette for the detection. Zeta potential of EVs was measured by the same instrument. The particle size distribution and concentration of isolated EVs were further determined by nanoparticle tracking analysis (NTA). Briefly, each sample was diluted 1:1000 in PBS and loaded into a 1-mL cuvette and placed into the instrument. Twenty-five videos with 3 frames per sec and 300 frames per video were recorded at 22°C. Software version 2.12/1.3.5 was used for the analysis. To characterize size and morphology through transmission electron microscopy (TEM), 3 µL of EVs purified by 12% PEG8000 and 0.5 M NaCl was loaded onto the 200-mesh size Formvar-carbon coated electron microscopy grids.Our results based on the DLS analysis revealing a normal distribution with mean EVs size of 266 nm and zeta potential measured to be -48 mV. Nanoparticle tracking analysis was conducted to confirm the size distribution and concentration of the isolated EVs. The average size of EVs separated by 12% PEG8000 was determined as 265 nm and the concentration of the diluted sample was calculated to be 1×107 particles/mL. Furthermore, TEM image exhibits the typical cup-shaped morphology of exosome-like EVs and large EVs, as well as some protein aggregates which has been reported in the literature. Western Blot Analysis. Our results indicated the EVs acquired by PEG-based precipitation approach reveal the surface protein expression of mammalian exosome associated tetraspanin family including CD9 (24 kDa), CD63 (60 kDa), and CD81 (26 kDa). The bands for endosomal sorting complex required for transport (ESCRT) dependent biogenic proteins TSG101 (50 kDa) and ALIX (95 kDa) were also clearly displayed. Additionally, no band was detected using Calnexin as a negative marker of exosomes. Infection of Arabidopsis thaliana. Pseudomonas syringe strain DC3000 colonies scraped from the agar plate were suspended in culture medium and grown to OD600 = 0.2. A. thaliana leaves were sprayed with the bacterial solution or a control solution without bacteria. Three days after the initial infection, apoplastic washing fluid (AWF) was collected from infected and mock plant leaves, respectively. The images of Arabidopsis thaliana post-infection with P. syringe for 3 days. Separation of PS-exposing EVs by Functionalized Chitin nanoparticles (NPs). The procedures of separating PS-exposing EVs by chitin NPs functionalized with lactadherin C1C2 were illustrated using 50 mM dithiothreitol (DTT) and 500 mM NaCl. The isolated EVs in the supernatant were analyzed for size, polydispersity, and zeta potential by dynamic light scattering device. The average size of collected EVs is around 117 nm with negatively charged. The EVs-chitin NP, EVs, and chitin NP were further analyzed by transmission electron microscopy (TEM). Infection of A. thaliana pre-treated with EVs from infected plant. A. thaliana leaves were sprayed with EVs purified from plant leaves infected with P. syringe for 3 days, and then infected with the bacterial solution for 3 days. Images of A. thaliana 3 days post-infection were taken under various conditions: (A) pre-treated with EVs collected from mock plant; (B) pre-treated with EVs purified from plant infected with P. syringe for 3 days; (C) no pre-treatment of EVs; (D) control (i.e., not infected). Our results showed that EVs separated from A. thaliana infected with P. syringe for 3 days could silence its virulence genes.

Publications

  • Type: Peer Reviewed Journal Articles Status: Published Year Published: 2024 Citation: Jokhio S, Peng, I, Peng CA. Extracellular vesicles isolated from Arabidopsis thaliana leaves reveal characteristics of mammalian exosomes. Protoplasma 261:1025-1033, 2024.
  • Type: Conference Papers and Presentations Status: Published Year Published: 2024 Citation: Peng, CA. Nanoparticle-based separation of plant extracellular vesicles for silencing virulence genes. 2024 GRC  Nanoscale Science and Engineering for Agriculture and Food Systems. Manchester, NH (June 23-28).
  • Type: Conference Papers and Presentations Status: Published Year Published: 2024 Citation: Jokhio S, Peng CA. Apoptosis of Myrosinase Gene Expressed Lung Cancer Cells Treated with Glucosinolate-Containing Extracellular Vesicles Isolated from Arabidopsis thaliana. 2024 AIChE Annual Meeting, San Diego, CA (Oct 27-31).


Progress 03/01/22 to 02/28/25

Outputs
Target Audience:- Research community investigating construction of recombinant plasmids, protein expression in transformed bacteria, and purification of fusion protein - Research community in the area of preventing pathogen infection using purified plant extracellular vesicles - Undergraduates and graduates involved with this research Changes/Problems: Nothing Reported What opportunities for training and professional development has the project provided? One PhD student is now familiar with recombinant plasmid construction, protein expression in T7-based bacteria system, and protein purification using affinity chromatography. This study has also learned to grow Arabidopsis thaliana and collect apoplastic washing fluids obtained from Arabidopsis leaves infected with pathogenic bacteria. The PhD student is in the final stage of completing the remaining experimental studies for the dissertation writing. One undergraduate student has been trained to grow A. thaliana, collect AWF, and use AWF to green synthesis of silver nanoparticles revealing anti-bacterial efficacy. How have the results been disseminated to communities of interest? The techniques of constructing, expressing, purifying, and characterizing lactadherin C1C2 fused proteins have been reported. The PEG-based precipitation of plant EVs have been published. One manuscript is under preparation for publishing the research outcomes of EVs separated from A. thaliana infected with P. syringe for 3 days could prevent Arabidopsis leaves from disease symptom (i.e., no yellowing or withering caused by P. syringe infection) over a long period of time. The other manuscript is also under preparation to report the efficient particle-based separation of plant EVs comparing to standard ultracentrifugation method. What do you plan to do during the next reporting period to accomplish the goals? Nothing Reported

Impacts
What was accomplished under these goals? Construction and Expression of lactadherin C1C2-streptavidin and pTXB1-lactadherin C1C2 encoding plasmid. The lactC1C2-SA encoding recombinant plasmid (pMA002) was constructed by inserting the gene sequences of lactadherin C1C2 domain into the multiple cloning sites from EcoRV and EcoRI in the established plasmid pMA001 (i.e., pET-30a(+)-coreSA). Moreover, we worked on an additional plasmid construction of pTXB1-CBD (chitin binding domain)-intein-C1C2. the gene encoding lactadherin C1C2 cloned by PCR were verified by DNA gel electrophoresis showing the size of ~0.9 kb on an agarose gel. The cloned lactadherin C1C2 was inserted between NdeI and SapI of pTXB1 plasmid. Collection of apoplastic washing fluid from Arabidopsis thaliana. Arabidopsis thaliana seeds [wild-type Arabidopsis thaliana (L.) Hyenh. Columbia-0 (Col-0)], obtained from Arabidopsis Biological Resource Center (Columbus, OH), planted by sprinkling uniformly over moist soil in plastic pots. The pots were then placed at 4°C for 4 days to allow enough time to properly germinate. On the 5th day, the pots were shifted to the growth chamber maintained at 22°C, and exposed to light (100 μmol/m2/s) with a cycle of 16 h on and 8 h off. A total of fifty leaves (fresh weight around 2 g) of 4-week-old Arabidopsis thaliana were cut at petioles, washed thrice with water, and dried on a paper towel. Dried leaves were then placed inside a needleless syringe and infiltrated with vesicle infiltration buffer. The apoplastic washing fluid (AWF) was collected, filtered with a 0.45-μm Nylon filter, and aliquoted 500 μL into three 1.5-mL microcentrifuge tubes which were stored at 4°C for follow-up experiments and at -80°C for long-term storage. Isolation of EVs from AWF by polyethylene glycol 8000 and sodium chloride. The collected AWFs (500 μL each) were mixed with various amounts of polyethylene glycol 8000 (PEG8000) to obtain 5%, 8% and 12% w/v concentration, respectively. The mixture was further added with NaCl to get 0.5 M salinity and then incubated at 4°C for 2 h and centrifuged at 10,000× g force for 30 min at 4°C using a microcentrifuge. The PEG-EVs agglomerates were sedimented at the bottom of the 1.5-mL microcentrifuge tube. The pellet was re-suspended in 1× phosphate buffered saline for characterization. Immuno dot blot assay. To examine the efficacy of EVs separated from AWF by the PEG-precipitation method, a dot blot assay was used. Briefly, for three different concentrations of PEG8000 used, 5 μL each from the supernatant and resuspended pellets was taken and carefully spotted on the nitrocellulose membrane. After 10 min of drying, the membranes were blocked using blocking buffer. Then, the membranes were incubated with mammalian monoclonal antibodies against tetraspanin proteins (CD9, CD63, and CD81) and PEG, respectively for 1 h at 4°C. After 1 h, the membranes were washed three times with TBST and incubated with secondary antibody (mouse IgG horseradish peroxide (HRP)-conjugated antibody in the blocking buffer at 1:1000 dilution) for 1 h at room temperature. Our results showed that there is an increase in pellet size with increasing concentration of PEG8000 from 5% to 12%. The precipitation of EVs was further verified by dot blot assay of both the pellet and supernatant. The dot blot analysis that was performed using the monoclonal antibodies against mammalian tetraspanin proteins CD9, CD63, and CD81, confirmed the presence of EVs in the pellet. Characterization of PEG-precipitated EVs. The measurements for the size distribution of EVs were performed with dynamic light scattering (DLS) instrument. EVs, resuspended in 1× PBS, were appropriately diluted with 0.2-μm membrane filtered distilled water and loaded into a 750-μL cuvette for the detection. Zeta potential of EVs was measured by the same instrument. The particle size distribution and concentration of isolated EVs were further determined by nanoparticle tracking analysis (NTA). Briefly, each sample was diluted 1:1000 in PBS and loaded into a 1-mL cuvette and placed into the instrument. Twenty-five videos with 3 frames per sec and 300 frames per video were recorded at 22°C. Software version 2.12/1.3.5 was used for the analysis. To characterize size and morphology through transmission electron microscopy (TEM), 3 μL of EVs purified by 12% PEG8000 and 0.5 M NaCl was loaded onto the 200-mesh size Formvar-carbon coated electron microscopy grids. Our results based on the DLS analysis revealing a normal distribution with mean EVs size of 266 nm and zeta potential measured to be -48 mV. Nanoparticle tracking analysis was conducted to confirm the size distribution and concentration of the isolated EVs. The average size of EVs separated by 12% PEG8000 was determined as 265 nm and the concentration of the diluted sample was calculated to be 1×107 particles/mL. Furthermore, TEM image exhibits the typical cup-shaped morphology of exosome-like EVs and large EVs, as well as some protein aggregates which has been reported in the literature. Western Blot Analysis. Our results indicated the EVs acquired by PEG-based precipitation approach reveal the surface protein expression of mammalian exosome associated tetraspanin family including CD9 (24 kDa), CD63 (60 kDa), and CD81 (26 kDa). The bands for endosomal sorting complex required for transport (ESCRT) dependent biogenic proteins TSG101 (50 kDa) and ALIX (95 kDa) were also clearly displayed. Additionally, no band was detected using Calnexin as a negative marker of exosomes. Infection of Arabidopsis thaliana. Pseudomonas syringe strain DC3000 colonies scraped from the agar plate were suspended in culture medium and grown to OD600 = 0.2. A. thaliana leaves were sprayed with the bacterial solution or a control solution without bacteria. Three days after the initial infection, apoplastic washing fluid (AWF) was collected from infected and mock plant leaves, respectively. The images of Arabidopsis thaliana post-infection with P. syringe for 3 days. Separation of PS-exposing EVs by Functionalized Chitin nanoparticles (NPs). The procedures of separating PS- exposing EVs by chitin NPs functionalized with lactadherin C1C2 were illustrated using 50 mM dithiothreitol (DTT) and 500 mM NaCl. The isolated EVs in the supernatant were analyzed for size, polydispersity, and zeta potential by dynamic light scattering device. The average size of collected EVs is around 117 nm with negatively charged. The EVs-chitin NP, EVs, and chitin NP were further analyzed by transmission electron microscopy (TEM). Infection of A. thaliana pre-treated with EVs from infected plant. A. thaliana leaves were sprayed with EVs purified from plant leaves infected with P. syringe for 3 days, and then infected with the bacterial solution for 3 days. Images of A. thaliana 3 days post-infection were taken under various conditions: (A) pre-treated with EVs collected from mock plant; (B) pre-treated with EVs purified from plant infected with P. syringe for 3 days; (C) no pre-treatment of EVs; (D) control (i.e., not infected). Our results showed that EVs separated from A. thaliana infected with P. syringe for 3 days could silence its virulence genes.

Publications

  • Type: Peer Reviewed Journal Articles Status: Published Year Published: 2024 Citation: Jokhio S, Peng, I, Peng CA. Extracellular vesicles isolated from Arabidopsis thaliana leaves reveal characteristics of mammalian exosomes. Protoplasma 261:1025-1033, 2024.
  • Type: Conference Papers and Presentations Status: Published Year Published: 2024 Citation: Jokhio S, Peng CA. Apoptosis of Myrosinase Gene Expressed Lung Cancer Cells Treated with Glucosinolate-Containing Extracellular Vesicles Isolated from Arabidopsis thaliana. 2024 AIChE Annual Meeting, San Diego, CA (Oct 27-31).
  • Type: Conference Papers and Presentations Status: Published Year Published: 2024 Citation: Peng, CA. Nanoparticle-based separation of plant extracellular vesicles for silencing virulence genes. 2024 GRC  Nanoscale Science and Engineering for Agriculture and Food Systems. Manchester, NH (June 23-28).


Progress 03/01/23 to 02/29/24

Outputs
Target Audience:- Research community in the area of preventing pathogen infection using isolated extracellular vesicles from plant treated with pathogens - Graduates involved with this research Changes/Problems:We will use Pseudomonas syringaerather than B. cinerea as the pathogen to infect Arabidopsis thaliana leaves. What opportunities for training and professional development has the project provided?One PhD student is now familiar with the expression and urification of lactC1C2-streptavidin fusion protein, thepreparation of functionalized nanoparticles for rapid isolation of plant EVs, collection of AWF from Arabidopsis thaliana leaves infected by pathogens. How have the results been disseminated to communities of interest?Some of the results have been reported in the A1511 PD meeting held at Universtiy of Tennessee Conference Center (from August 10 to 11). What do you plan to do during the next reporting period to accomplish the goals?We will examine the efficacy of EVs isolated from infected Arabidopsis thaliana leaves revealing silencing virulence genes of pathogens.

Impacts
What was accomplished under these goals? The purified lactC1C2-streptavidin fusion protein was bound with biotinylated nanoparticles. The functionalized nanoparticles were able to rapidly isolate extracellular vesicles from apoplastic washing fluid (AWF) obtained bt infiltratingArabidopsis thaliana leaves pre-infected wtih pathogens.The mean size of purified Arabidopsis thaliana EVs determined by dynamic light scattering was 266 nm, which is consistent with nanoparticle tracking analysis. The size was also confirmed via transmission electron microscopy with morphology of a cup-shaped appearance which is the typical mammalian exosome's morphology. Additionally, Western blotting of the purified Arabidopsis thaliana EVs, using commercially available mammalian exosomal kits, displayed surface marker tetraspanin proteins (CD9, CD63, and CD81), and endosomal sorting complexes required for transport (ESCRT)-associated proteins (TSG101 and ALIX). This demonstrates that the purified Arabidopsis thaliana EVs reveal the typical proteins reported in mammalian exosomes.

Publications


    Progress 03/01/22 to 02/28/23

    Outputs
    Target Audience:- Research community investigating construction of recombinant plasmids, protein expression in transformed bacteria, and purification of fusion protein - Research community in the area of preventing pathogen infection using purifiedplant extracellular vesicles - Undergraduates and graduates involved with this research Changes/Problems: Nothing Reported What opportunities for training and professional development has the project provided?One PhD student is now familiar with recominant plasmid construction, protein expression in T7-based bacteria system, and protein purification using affinity chromatography. This study has also learned to grow Arabidopsis thaliana and collect apoplastic washing fluids obtained from Arabidopsis leaves infected with pathogenic bacteria. How have the results been disseminated to communities of interest? Nothing Reported What do you plan to do during the next reporting period to accomplish the goals?We will construct and characterize biotinylated nanoparticles for tethering the lactC1C2-SA fusion protein purified from this report period. The purified plant extracellular vesicles will be further used to spray onArabidopsis thaliana leaves to investigate the potency of preventing infection.

    Impacts
    What was accomplished under these goals? ThelactC1C2-coreSA encoding recombinant plasmid (pMA002) wasconstructed by inserting the gene sequences of lactadherin C1C2 domain into the multiple cloning sites from EcoRV and EcoRI in the established plasmid pMA001 (i.e., pET-30a(+)-coreSA). The lactC1C2 domain gene was cloned from the plasmid encoding C1C2 domain, acquired from Addgene (plasmid Cat # 52987), by polymerase chain reaction (PCR) with forward primer 5'- ATTAAGATATCTGTTCTACACAGCTGGGC-3' and reverse primer 5'-ATTAAGAATTCACAGCCCAGC AGCTCCAG-3'. LactC1C2 PCR reactions were performed with previous reportedDNA polymerase, times, temperatures, and cycles. The PCR products of lactC1C2 were purified through the PCR purification kit (NEB) and analyzed by 1% agarose gel electrophoresis. The pMA001 plasmid and lactC1C2 cDNA (insert) were cut with restriction enzymes EcoRV and EcoRI. The digested pMA001 and lactC1C2 products were ligased to get the pMA002 plasmid. The pMA002 ligation product was amplified by transformation with subcloning efficiency DH5α competent cells and purified by QIAGEN Plasmid Maxi Kit. The gene sequences encoding lactC1C2 and coreSA from pMA002 cloned by PCR were verified by DNA gel electrophoresis. The constructed pMA002 plasmid was transformed into T7 Express Lemo21(DE3) competent E. coli cells and had lactC1C2-coreSA fusion protein expressed using the protocols reported in public accounts. Expressed lactC1C2-coreSA fusion protein with 6×His tag was purified by IMAC Co-NTA affinity chromatography and characterized by SDS?PAGE and Western blotting analysis.The purified lactC1C2-coreSA fusion protein can be easily bound onto biotinylated chitosan nanoparticles.

    Publications